The Bioactive Lipid 4-Hydroxyphenyl Retinamide Inhibits Flavivirus Replication

Antimicrobial Agents and Chemotherapy - Tập 59 Số 1 - Trang 85-95 - 2015
Margot Carocci1, Stephen M. Hinshaw2, Mary A. Rodgers1, Valerie A. Villareal1, Dominique J. Burri1, Rajendra Pilankatta1, Natalya P. Maharaj1, Michaela U. Gack1, Eric Stavale3, Kelly L. Warfield3, Priscilla L. Yang1
1Harvard Medical School, Department of Microbiology and Immunobiology, Boston, Massachusetts, USA.
2Harvard Medical School, Department of Biological Chemistry and Molecular Pharmacology, Boston, Massachusetts, USA
3Integrated Biotherapeutics, Gaithersburg, Maryland, USA.

Tóm tắt

ABSTRACT Dengue virus (DENV), a member of the Flaviviridae family, is a mosquito-borne pathogen and the cause of dengue fever. The increasing prevalence of DENV worldwide heightens the need for an effective vaccine and specific antivirals. Due to the dependence of DENV upon the lipid biosynthetic machinery of the host cell, lipid signaling and metabolism present unique opportunities for inhibiting viral replication. We screened a library of bioactive lipids and modulators of lipid metabolism and identified 4-hydroxyphenyl retinamide (4-HPR) (fenretinide) as an inhibitor of DENV in cell culture. 4-HPR inhibits the steady-state accumulation of viral genomic RNA and reduces viremia when orally administered in a murine model of DENV infection. The molecular target responsible for this antiviral activity is distinct from other known inhibitors of DENV but appears to affect other members of the Flaviviridae , including the West Nile, Modoc, and hepatitis C viruses. Although long-chain ceramides have been implicated in DENV replication, we demonstrate that DENV is insensitive to the perturbation of long-chain ceramides in mammalian cell culture and that the effect of 4-HPR on dihydroceramide homeostasis is separable from its antiviral activity. Likewise, the induction of reactive oxygen species by 4-HPR is not required for the inhibition of DENV. The inhibition of DENV in vivo by 4-HPR, combined with its well-established safety and tolerability in humans, suggests that it may be repurposed as a pan- Flaviviridae antiviral agent. This work also illustrates the utility of bioactive lipid screens for identifying critical interactions of DENV and other viral pathogens with host lipid biosynthesis, metabolism, and signal transduction.

Từ khóa


Tài liệu tham khảo

10.1038/nature12060

10.1146/annurev-immunol-031210-101315

10.1007/s00705-013-1645-3

10.1016/j.mib.2012.05.013

10.1158/1078-0432.CCR-06-1889

10.1073/pnas.0611681104

10.1128/JVI.00224-12

10.1021/ja207391q

10.1371/journal.ppat.1002627

10.1007/978-1-59745-394-3_24

10.1007/978-1-59745-394-3_27

10.1099/0022-1317-73-11-2999

10.1038/nmeth.2089

10.1016/j.virol.2008.06.034

10.1128/JVI.02042-09

10.1128/JVI.00632-13

10.1186/1743-422X-3-89

10.1128/JVI.00384-12

10.1074/jbc.M110.192500

10.1371/journal.pntd.0000672

10.1016/j.antiviral.2011.08.003

10.1021/ja809949r

10.1002/rcm.878

10.1074/jbc.274.43.30580

10.1016/j.antiviral.2009.09.011

10.1016/j.virusres.2013.03.005

10.1073/pnas.1010811107

10.1021/bi980744d

10.1074/jbc.M209962200

Wang H, Maurer BJ, Reynolds CP, Cabot MC. 2001. N-(4-Hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res 61:5102–5105.

10.1074/jbc.M111.250779

10.1371/journal.ppat.1002584

10.1099/vir.0.055616-0

10.1099/vir.0.028159-0

10.1128/JVI.00968-08

10.1002/ijc.20923

10.1093/jnci/91.21.1847

10.1111/j.1365-2230.1986.tb00520.x

10.2337/db12-0458

10.1097/IAE.0b013e318265801d

10.1006/viro.2002.1685

10.1016/j.antiviral.2011.10.002

10.1086/511310

10.1016/j.antiviral.2012.07.008

10.1016/j.antiviral.2005.11.002

10.1128/JVI.00300-07

10.1371/journal.ppat.1000244

10.1371/journal.ppat.1001131

10.1074/jbc.M512697200

10.1099/vir.0.81655-0

10.1128/JVI.05468-11

10.1016/j.antiviral.2013.05.011

10.1006/excr.2000.4988

Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL. 2003. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. Clin Cancer Res 9:4606–4613.

10.1152/ajpendo.00362.2009

10.1093/carcin/bgs234

10.1093/jnci/91.13.1138

10.1158/1535-7163.MCT-08-0549

10.1128/JVI.02499-09

10.1007/s10495-006-9289-3

10.1111/j.1476-5381.2011.01310.x

10.1093/infdis/jiu319

Thông tin
Thông tin xuất bản

Antimicrobial Agents and Chemotherapy

Tập 59 Số 1

85-95

Thông tin tác giả